- Home
- GMGI vs CMPX Comparison
GMGI vs CMPX Comparison
Compare GMGI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- CMPX
- Stock Information
- Founded
- GMGI 2008
- CMPX 2014
- Country
- GMGI United States
- CMPX United States
- Employees
- GMGI N/A
- CMPX N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- CMPX Health Care
- Exchange
- GMGI Nasdaq
- CMPX Nasdaq
- Market Cap
- GMGI 261.2M
- CMPX 291.8M
- IPO Year
- GMGI N/A
- CMPX N/A
- Fundamental
- Price
- GMGI $1.72
- CMPX $2.78
- Analyst Decision
- GMGI Strong Buy
- CMPX Strong Buy
- Analyst Count
- GMGI 1
- CMPX 9
- Target Price
- GMGI $4.00
- CMPX $12.67
- AVG Volume (30 Days)
- GMGI 198.8K
- CMPX 929.9K
- Earning Date
- GMGI 08-12-2025
- CMPX 08-11-2025
- Dividend Yield
- GMGI N/A
- CMPX N/A
- EPS Growth
- GMGI N/A
- CMPX N/A
- EPS
- GMGI N/A
- CMPX N/A
- Revenue
- GMGI $168,987,998.00
- CMPX $850,000.00
- Revenue This Year
- GMGI $28.44
- CMPX N/A
- Revenue Next Year
- GMGI $18.24
- CMPX N/A
- P/E Ratio
- GMGI N/A
- CMPX N/A
- Revenue Growth
- GMGI 77.72
- CMPX N/A
- 52 Week Low
- GMGI $1.33
- CMPX $0.77
- 52 Week High
- GMGI $3.10
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- GMGI 49.11
- CMPX 68.90
- Support Level
- GMGI $1.66
- CMPX $2.50
- Resistance Level
- GMGI $1.87
- CMPX $2.71
- Average True Range (ATR)
- GMGI 0.10
- CMPX 0.19
- MACD
- GMGI 0.01
- CMPX 0.01
- Stochastic Oscillator
- GMGI 52.46
- CMPX 87.14
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.